Evidence map›Paper›PMID 30233586›Full record

ReviewFrontiers in immunology2018

Emerging Developments in Microbiome and Microglia Research: Implications for Neurodevelopmental Disorders.

Yeonwoo Lebovitz, Veronica M Ringel-Scaia, Irving C Allen, Michelle H Theus

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Gene×environment interactions in autism spectrum disorders.Current topics in developmental biology · 2023
    Review
  3. Review
  4. Review
  5. Article
  6. A Developmental Analysis of Juxtavascular Microglia Dynamics and Interactions with the Vasculature.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yeonwoo LebovitzGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.
Veronica M Ringel-ScaiaGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.
Irving C AllenGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.
Michelle H TheusGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.

Funding

Mechanisms Regulating Cerebral Arteriogenesis and NeurorestorationR01NS096281 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI THEUS, MICHELLE LEE · 2016 to 2020
$1.9M
COLLATERAL FORMATION AND REMODELING AFTER ISCHEMIC STROKER15NS081623 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI THEUS, MICHELLE LEE · 2013 to 2013
$483k
Evaluating NLR Modulation of Canonical and Non-Canonical NF-kB Signaling in IBDR03DK105975 · NIDDK · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI ALLEN, IRVING C · 2015 to 2016
$161k
NIDDK NIH HHS R03 DK105975NINDS NIH HHS R01 NS096281NINDS NIH HHS R15 NS081623
6 · The paper itself

Abstract

From immunology to neuroscience, interactions between the microbiome and host are increasingly appreciated as potent drivers of health and disease. Epidemiological studies previously identified compelling correlations between perinatal microbiome insults and neurobehavioral outcomes, the mechanistic details of which are just beginning to take shape thanks to germ-free and antibiotics-based animal models. This review summarizes parallel developments from clinical and preclinical research that suggest neuroactive roles for gut bacteria and their metabolites. We also examine the nascent field of microbiome-microglia crosstalk research, which includes pharmacological and genetic strategies to inform functional capabilities of microglia in response to microbial programming. Finally, we address an emerging hypothesis behind neurodevelopmental disorders, which implicates microbiome dysbiosis in the atypical programming of neuroimmune cells, namely microglia.

Indexed as

MicrobiotaNeuroimmunomodulationAnimalsAutism Spectrum DisorderBehaviorCellular ReprogrammingDisease Models, AnimalDysbiosisHumansLactobacillusMicrogliaNeurodevelopmental Disordersautismbacterial metabolitesgut bacterialactobacillusmicrobiotaneurodevelopmentneuroimmune

Identifiers

PMID30233586
PMCPMC6129765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.